Intellia Therapeutics Inc. (formerly known as AZRN Inc.) was founded in 2014 and is headquartered in Cambridge, Massachusetts. The company is currently focused on gene editing and the development of therapeutics based on a unique biological tool called CRISPR/Cas9 system. Company products are meant to... Show More
📉 WHY EDITAS MEDICINE SELLOFF LOOKS OVERDONE?
🔸 What Happened to the stock?
The shares of Editas Medicine dropped more than 15% last Friday, after Goldman Sachs initiated coverage on $EDIT (Editas Medicine Inc) stock with a “Sell” rating and a $20 price target. At the time, the stock price was around... Show More